Smart insulin system could ease diabetes management for type 2 patients
NCT ID NCT06959797
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fully closed-loop insulin system (which automatically adjusts insulin delivery) works better than a standard insulin pump for people with type 2 diabetes. Eighty adults who have used an insulin pump for at least six months will try both methods for 12 weeks each. The goal is to see which approach keeps blood sugar in a healthy range more consistently and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Closed-loop automated insulin delivery system (Ypsomed pump, CamAPS HX app, Freestyle Libre 3 sensor)
What this could lead to
If successful, this could show that a fully automated insulin system helps people with type 2 diabetes maintain better blood sugar levels with less effort than a standard pump.
What could go wrong
This is a relatively small, early-stage crossover study (80 participants). The system may not work for everyone, and there are risks of hypoglycemia or device issues. Results may not apply to all type 2 diabetes patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Caen University Hospital
RECRUITINGCaen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••